NCT00245856|CompletedPhase 4Results
Loading search results
Sponsor study identifier
Secondary identifiers
OTHER · University of Oklahoma Office of Research Administration
interventional
67
1 country
2
Study Start
September 2002
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2009
Actual (reported)Study Completion
December 2011
Actual (reported)The purpose of this study is to document the long-term outcome or prognosis of patients diagnosed with upper extremity deep-vein thrombosis who are treated with Fragmin (dalteparin sodium injection) for three months.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2011
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2002
Date type not reportedThis date has not been verified as actual or estimated.
October 26, 2005
Actual (reported)October 28, 2005
Actual (reported)March 2009
Actual (reported)December 2011
Actual (reported)February 4, 2013
Actual (reported)Percentage of Participants That Died at 3 Months
3 months
New Venous Thromboembolism at 3 Months
New DVT or PE at 3 months confirmed by diagnostic testing
3 months
Bleeding Events
3 months
Participants received dalterparin followed by warfarin or received dalterparin monotherapy for the treatment of upper extremity DVT
200units/kg subcutaneous daily for one month, followed by 150units/kg subcutaneous daily for two additional months or 200 units/kg subcutaneously daily for 5 days followed by warfarin.
Titrated to INR 2-3 through study month 3
Department of Veterans Affairs Medical Center
Oklahoma City, Oklahoma, 73104, United States
University of Oklahoma Health Science Center
Oklahoma City, Oklahoma, 73117, United States
Suman W. Rathbun, M.D.
University of Oklahoma Health Science Center, Dept of Medicine/CardioVascular section
67 participants (actual enrollment reported by the registry).
First Submitted
October 26, 2005
First Posted
October 28, 2005
Study Start
September 2002
Date type not reportedThis date has not been verified as actual or estimated.
Safety and Efficacy Study of OmniWave Endovascular System to Treat Deep Vein Thrombosis
Contact the study team to confirm eligibility.
Primary Completion
March 2009
Actual (reported)Study Completion
December 2011
Actual (reported)Last Updated
February 21, 2013
Results First Posted
February 4, 2013
Record last verified: 2013-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: